BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 21094799)

  • 1. The clinical importance of flow cytometry crossmatch in the context of CDC crossmatch results.
    Graff RJ; Buchanan PM; Dzebisashvili N; Schnitzler MA; Tuttle-Newhall J; Xiao H; Schadde E; Gheorghian A; Lentine KL
    Transplant Proc; 2010 Nov; 42(9):3471-4. PubMed ID: 21094799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplantation with positive complement-dependent microcytotoxicity crossmatch in contemporary kidney transplantation: Practice patterns and associated outcomes.
    Graff RJ; Xiao H; Duffy B; Schnitzler MA; Axelrod D; Lentine KL
    Saudi J Kidney Dis Transpl; 2012 Mar; 23(2):234-45. PubMed ID: 22382213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometry crossmatch before kidney transplantation in contemporary practice: target cell utilization, results patterns, and associated long-term graft survival.
    Lentine KL; Graff RJ; Xiao H; Modanlou KA; Salvalaggio PR; Brennan DC; Pinsky BW; Burroughs TE; Schnitzler MA
    Clin Transpl; 2008; ():253-66. PubMed ID: 19708460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Living-donor kidney transplant in T-cell and B-cell flow cytometry crossmatch-positive patients.
    Terasaka S; Kitada H; Okabe Y; Kawanami S; Noguchi H; Miyamoto K; Tsuchimoto A; Masutani K; Tanaka M
    Exp Clin Transplant; 2014 Jun; 12(3):227-32. PubMed ID: 24907723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic flow cytometric crossmatch in renal transplantation: a single assay to simultaneously detect antibody binding and cytotoxicity.
    Thammanichanond D; Athimang W; Paisooksantivatana K; Mongkolsuk T; Ingsathit A; Worawichawong S; Kitpoka P; Jirasiritham S; Kantachuvesiri S
    Transplant Proc; 2012 Jan; 44(1):62-5. PubMed ID: 22310580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Flow cytometry crossmatching (FCXM) in the UNOS Kidney Transplant Registry.
    Cook DJ; Fettouh HI; Gjertson DW; Cecka JM
    Clin Transpl; 1998; ():413-9. PubMed ID: 10503119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive B-cell only flow cytometric crossmatch: implications for renal transplantation.
    Delgado JC; Eckels DD
    Exp Mol Pathol; 2008 Aug; 85(1):59-63. PubMed ID: 18499103
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pretransplant donor-specific HLA antibodies detected by single antigen bead flow cytometry: risk factors and outcomes after kidney transplantation.
    Kanter Berga J; Sancho Calabuig A; Gavela Martinez E; Puig Alcaraz N; Beltran Catalan S; Avila Bernabeu A; Crespo Albiach J; Montoro JA; Pallardo Mateu LM
    Transplant Proc; 2012 Nov; 44(9):2529-31. PubMed ID: 23146444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relevance of posttransplant flow cytometric T- and B-cell crossmatches in tacrolimus-treated renal transplant patients.
    Lenaers JI; Christiaans MH; Voorter CE; van Hooff HP; van den Berg-Loonen EM
    Transplantation; 2006 Nov; 82(9):1142-7. PubMed ID: 17102764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The crossmatch in renal transplantation. Evaluation of flow cytometry as a replacement for standard cytotoxicity.
    Scornik JC; Brunson ME; Schaub B; Howard RJ; Pfaff WW
    Transplantation; 1994 Feb; 57(4):621-5. PubMed ID: 8116050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor kidney allograft survival associated with positive B cell - Only flow cytometry cross matches: a ten year single center study.
    Norin AJ; Mondragon-Escorpizo MO; Brar A; Hochman D; Sumrani N; Distant DA; Salifu MO
    Hum Immunol; 2013 Oct; 74(10):1304-12. PubMed ID: 23811689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved graft survival in highly sensitized patients undergoing renal transplantation after the introduction of a clinically validated flow cytometry crossmatch.
    Limaye S; O'Kelly P; Harmon G; O'Neill D; Dorman AM; Walshe J; Donohoe J; Little D; Conlon PJ; Keogan MT
    Transplantation; 2009 Apr; 87(7):1052-6. PubMed ID: 19352127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kidney transplantation with positive complement-dependent lymphocytotoxicity crossmatch with negative flow crossmatching and Luminexx donor-specific antibodies.
    Kute VB; Vanikar AV; Gumber MR; Trivedi VB; Shah PR; Patel HV; Balwani MR; Modi PR; Trivedi HL
    Ren Fail; 2013 Aug; 35(7):1027-30. PubMed ID: 23829775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T-cell flow-cytometry crossmatch and long-term renal graft survival.
    Rebibou JM; Bittencourt MC; Saint-Hillier Y; Chabod J; Dupont I; Bittard H; Chalopin JM; Hervé P; Tiberghien P
    Clin Transplant; 2004 Oct; 18(5):558-63. PubMed ID: 15344960
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modified flow cytometry crossmatch detecting alloantibody-related cytotoxicity as a way to distinguish lytic antibodies from harmless in allosensitised kidney recipients.
    Zieliński M; Zielińska H; Moszkowska G; Dȩbska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2013; 45(1):88-94. PubMed ID: 23375279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Organ procurement and transplantation network/united network for organ sharing histocompatibility committee collaborative study to evaluate prediction of crossmatch results in highly sensitized patients.
    Nikaein A; Cherikh W; Nelson K; Baker T; Leffell S; Bow L; Crowe D; Connick K; Head MA; Kamoun M; Kimball P; Klohe E; Noreen H; Rebellato L; Sell T; Sullivan K; Land G
    Transplantation; 2009 Feb; 87(4):557-62. PubMed ID: 19307794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implications of a positive crossmatch in liver transplantation: a 20-year review.
    Ruiz R; Tomiyama K; Campsen J; Goldstein RM; Levy MF; McKenna GJ; Onaca N; Susskind B; Tillery GW; Klintmalm GB
    Liver Transpl; 2012 Apr; 18(4):455-60. PubMed ID: 22139972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High negative predictive value of an amplified flow cytometry crossmatch before living donor kidney transplantation.
    Lindemann M; Nyadu B; Heinemann FM; Kribben A; Paul A; Horn PA; Witzke O
    Hum Immunol; 2010 Aug; 71(8):771-6. PubMed ID: 20457201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.